世界のメラノコルチン受容体4市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Melanocortin Receptor 4 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5849 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、メラノコルチン受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブレメラノチド、コルチコトロピン、コシントロピン、その他）、用途別市場規模（代謝障害、女性健康、泌尿生殖器系、感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・メラノコルチン受容体4の市場動向 ・企業の競争状況、市場シェア ・メラノコルチン受容体4の種類別市場規模と予測2016-2027（ブレメラノチド、コルチコトロピン、コシントロピン、その他） ・メラノコルチン受容体4の用途別市場規模と予測2016-2027（代謝障害、女性健康、泌尿生殖器系、感染症、その他） ・メラノコルチン受容体4の北米市場規模2016-2027（アメリカ、カナダ） ・メラノコルチン受容体4の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・メラノコルチン受容体4のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メラノコルチン受容体4の中南米市場規模2016-2027（メキシコ、ブラジル） ・メラノコルチン受容体4の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca Plc、Mallinckrodt Plc、Obexia AG、Palatin Technologies, Inc.、Pfizer Inc.、Retrophin Inc.、Rhythm Pharmaceuticals, Inc.） ・結論

Market Analysis and Insights: Global Melanocortin Receptor 4 Market
The global Melanocortin Receptor 4 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanocortin Receptor 4 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanocortin Receptor 4 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanocortin Receptor 4 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanocortin Receptor 4 market.

Global Melanocortin Receptor 4 Scope and Market Size
Melanocortin Receptor 4 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanocortin Receptor 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bremelanotide
Corticotropin
Cosyntropin
Others

Segment by Application
Metabolic Disorder
Women’s Health
Genito Urinary System
Infection Disease
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca Plc
Mallinckrodt Plc
Obexia AG
Palatin Technologies, Inc.
Pfizer Inc.
Retrophin Inc.
Rhythm Pharmaceuticals, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bremelanotide
1.2.3 Corticotropin
1.2.4 Cosyntropin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Melanocortin Receptor 4 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Metabolic Disorder
1.3.3 Women’s Health
1.3.4 Genito Urinary System
1.3.5 Infection Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Melanocortin Receptor 4 Market Perspective (2016-2027)
2.2 Melanocortin Receptor 4 Growth Trends by Regions
2.2.1 Melanocortin Receptor 4 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melanocortin Receptor 4 Historic Market Share by Regions (2016-2021)
2.2.3 Melanocortin Receptor 4 Forecasted Market Size by Regions (2022-2027)
2.3 Melanocortin Receptor 4 Industry Dynamic
2.3.1 Melanocortin Receptor 4 Market Trends
2.3.2 Melanocortin Receptor 4 Market Drivers
2.3.3 Melanocortin Receptor 4 Market Challenges
2.3.4 Melanocortin Receptor 4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Melanocortin Receptor 4 Players by Revenue
3.1.1 Global Top Melanocortin Receptor 4 Players by Revenue (2016-2021)
3.1.2 Global Melanocortin Receptor 4 Revenue Market Share by Players (2016-2021)
3.2 Global Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melanocortin Receptor 4 Revenue
3.4 Global Melanocortin Receptor 4 Market Concentration Ratio
3.4.1 Global Melanocortin Receptor 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanocortin Receptor 4 Revenue in 2020
3.5 Melanocortin Receptor 4 Key Players Head office and Area Served
3.6 Key Players Melanocortin Receptor 4 Product Solution and Service
3.7 Date of Enter into Melanocortin Receptor 4 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Melanocortin Receptor 4 Breakdown Data by Type
4.1 Global Melanocortin Receptor 4 Historic Market Size by Type (2016-2021)
4.2 Global Melanocortin Receptor 4 Forecasted Market Size by Type (2022-2027)

5 Melanocortin Receptor 4 Breakdown Data by Application
5.1 Global Melanocortin Receptor 4 Historic Market Size by Application (2016-2021)
5.2 Global Melanocortin Receptor 4 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Melanocortin Receptor 4 Market Size (2016-2027)
6.2 North America Melanocortin Receptor 4 Market Size by Type
6.2.1 North America Melanocortin Receptor 4 Market Size by Type (2016-2021)
6.2.2 North America Melanocortin Receptor 4 Market Size by Type (2022-2027)
6.2.3 North America Melanocortin Receptor 4 Market Size by Type (2016-2027)
6.3 North America Melanocortin Receptor 4 Market Size by Application
6.3.1 North America Melanocortin Receptor 4 Market Size by Application (2016-2021)
6.3.2 North America Melanocortin Receptor 4 Market Size by Application (2022-2027)
6.3.3 North America Melanocortin Receptor 4 Market Size by Application (2016-2027)
6.4 North America Melanocortin Receptor 4 Market Size by Country
6.4.1 North America Melanocortin Receptor 4 Market Size by Country (2016-2021)
6.4.2 North America Melanocortin Receptor 4 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Melanocortin Receptor 4 Market Size (2016-2027)
7.2 Europe Melanocortin Receptor 4 Market Size by Type
7.2.1 Europe Melanocortin Receptor 4 Market Size by Type (2016-2021)
7.2.2 Europe Melanocortin Receptor 4 Market Size by Type (2022-2027)
7.2.3 Europe Melanocortin Receptor 4 Market Size by Type (2016-2027)
7.3 Europe Melanocortin Receptor 4 Market Size by Application
7.3.1 Europe Melanocortin Receptor 4 Market Size by Application (2016-2021)
7.3.2 Europe Melanocortin Receptor 4 Market Size by Application (2022-2027)
7.3.3 Europe Melanocortin Receptor 4 Market Size by Application (2016-2027)
7.4 Europe Melanocortin Receptor 4 Market Size by Country
7.4.1 Europe Melanocortin Receptor 4 Market Size by Country (2016-2021)
7.4.2 Europe Melanocortin Receptor 4 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Melanocortin Receptor 4 Market Size (2016-2027)
8.2 Asia-Pacific Melanocortin Receptor 4 Market Size by Type
8.2.1 Asia-Pacific Melanocortin Receptor 4 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melanocortin Receptor 4 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melanocortin Receptor 4 Market Size by Type (2016-2027)
8.3 Asia-Pacific Melanocortin Receptor 4 Market Size by Application
8.3.1 Asia-Pacific Melanocortin Receptor 4 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melanocortin Receptor 4 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melanocortin Receptor 4 Market Size by Application (2016-2027)
8.4 Asia-Pacific Melanocortin Receptor 4 Market Size by Region
8.4.1 Asia-Pacific Melanocortin Receptor 4 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melanocortin Receptor 4 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Melanocortin Receptor 4 Market Size (2016-2027)
9.2 Latin America Melanocortin Receptor 4 Market Size by Type
9.2.1 Latin America Melanocortin Receptor 4 Market Size by Type (2016-2021)
9.2.2 Latin America Melanocortin Receptor 4 Market Size by Type (2022-2027)
9.2.3 Latin America Melanocortin Receptor 4 Market Size by Type (2016-2027)
9.3 Latin America Melanocortin Receptor 4 Market Size by Application
9.3.1 Latin America Melanocortin Receptor 4 Market Size by Application (2016-2021)
9.3.2 Latin America Melanocortin Receptor 4 Market Size by Application (2022-2027)
9.3.3 Latin America Melanocortin Receptor 4 Market Size by Application (2016-2027)
9.4 Latin America Melanocortin Receptor 4 Market Size by Country
9.4.1 Latin America Melanocortin Receptor 4 Market Size by Country (2016-2021)
9.4.2 Latin America Melanocortin Receptor 4 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Melanocortin Receptor 4 Market Size (2016-2027)
10.2 Middle East & Africa Melanocortin Receptor 4 Market Size by Type
10.2.1 Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2016-2027)
10.3 Middle East & Africa Melanocortin Receptor 4 Market Size by Application
10.3.1 Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2016-2027)
10.4 Middle East & Africa Melanocortin Receptor 4 Market Size by Country
10.4.1 Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Melanocortin Receptor 4 Introduction
11.1.4 AstraZeneca Plc Revenue in Melanocortin Receptor 4 Business (2016-2021)
11.1.5 AstraZeneca Plc Recent Development
11.2 Mallinckrodt Plc
11.2.1 Mallinckrodt Plc Company Details
11.2.2 Mallinckrodt Plc Business Overview
11.2.3 Mallinckrodt Plc Melanocortin Receptor 4 Introduction
11.2.4 Mallinckrodt Plc Revenue in Melanocortin Receptor 4 Business (2016-2021)
11.2.5 Mallinckrodt Plc Recent Development
11.3 Obexia AG
11.3.1 Obexia AG Company Details
11.3.2 Obexia AG Business Overview
11.3.3 Obexia AG Melanocortin Receptor 4 Introduction
11.3.4 Obexia AG Revenue in Melanocortin Receptor 4 Business (2016-2021)
11.3.5 Obexia AG Recent Development
11.4 Palatin Technologies, Inc.
11.4.1 Palatin Technologies, Inc. Company Details
11.4.2 Palatin Technologies, Inc. Business Overview
11.4.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Introduction
11.4.4 Palatin Technologies, Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021)
11.4.5 Palatin Technologies, Inc. Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Melanocortin Receptor 4 Introduction
11.5.4 Pfizer Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development
11.6 Retrophin Inc.
11.6.1 Retrophin Inc. Company Details
11.6.2 Retrophin Inc. Business Overview
11.6.3 Retrophin Inc. Melanocortin Receptor 4 Introduction
11.6.4 Retrophin Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021)
11.6.5 Retrophin Inc. Recent Development
11.7 Rhythm Pharmaceuticals, Inc.
11.7.1 Rhythm Pharmaceuticals, Inc. Company Details
11.7.2 Rhythm Pharmaceuticals, Inc. Business Overview
11.7.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Introduction
11.7.4 Rhythm Pharmaceuticals, Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021)
11.7.5 Rhythm Pharmaceuticals, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Melanocortin Receptor 4 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bremelanotide
Table 3. Key Players of Corticotropin
Table 4. Key Players of Cosyntropin
Table 5. Key Players of Others
Table 6. Global Melanocortin Receptor 4 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Melanocortin Receptor 4 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Melanocortin Receptor 4 Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Melanocortin Receptor 4 Market Share by Regions (2016-2021)
Table 10. Global Melanocortin Receptor 4 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Melanocortin Receptor 4 Market Share by Regions (2022-2027)
Table 12. Melanocortin Receptor 4 Market Trends
Table 13. Melanocortin Receptor 4 Market Drivers
Table 14. Melanocortin Receptor 4 Market Challenges
Table 15. Melanocortin Receptor 4 Market Restraints
Table 16. Global Melanocortin Receptor 4 Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Melanocortin Receptor 4 Market Share by Players (2016-2021)
Table 18. Global Top Melanocortin Receptor 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanocortin Receptor 4 as of 2020)
Table 19. Ranking of Global Top Melanocortin Receptor 4 Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Melanocortin Receptor 4 Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Melanocortin Receptor 4 Product Solution and Service
Table 23. Date of Enter into Melanocortin Receptor 4 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Melanocortin Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Melanocortin Receptor 4 Revenue Market Share by Type (2016-2021)
Table 27. Global Melanocortin Receptor 4 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Melanocortin Receptor 4 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Melanocortin Receptor 4 Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Melanocortin Receptor 4 Revenue Market Share by Application (2016-2021)
Table 31. Global Melanocortin Receptor 4 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Melanocortin Receptor 4 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Melanocortin Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Melanocortin Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Melanocortin Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Melanocortin Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Melanocortin Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Melanocortin Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Melanocortin Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Melanocortin Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Melanocortin Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Melanocortin Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Melanocortin Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Melanocortin Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Melanocortin Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Melanocortin Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Melanocortin Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Melanocortin Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Melanocortin Receptor 4 Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Melanocortin Receptor 4 Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Melanocortin Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Melanocortin Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Melanocortin Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Melanocortin Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Melanocortin Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Melanocortin Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Melanocortin Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Melanocortin Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Melanocortin Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Plc Company Details
Table 64. AstraZeneca Plc Business Overview
Table 65. AstraZeneca Plc Melanocortin Receptor 4 Product
Table 66. AstraZeneca Plc Revenue in Melanocortin Receptor 4 Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Plc Recent Development
Table 68. Mallinckrodt Plc Company Details
Table 69. Mallinckrodt Plc Business Overview
Table 70. Mallinckrodt Plc Melanocortin Receptor 4 Product
Table 71. Mallinckrodt Plc Revenue in Melanocortin Receptor 4 Business (2016-2021) & (US$ Million)
Table 72. Mallinckrodt Plc Recent Development
Table 73. Obexia AG Company Details
Table 74. Obexia AG Business Overview
Table 75. Obexia AG Melanocortin Receptor 4 Product
Table 76. Obexia AG Revenue in Melanocortin Receptor 4 Business (2016-2021) & (US$ Million)
Table 77. Obexia AG Recent Development
Table 78. Palatin Technologies, Inc. Company Details
Table 79. Palatin Technologies, Inc. Business Overview
Table 80. Palatin Technologies, Inc. Melanocortin Receptor 4 Product
Table 81. Palatin Technologies, Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021) & (US$ Million)
Table 82. Palatin Technologies, Inc. Recent Development
Table 83. Pfizer Inc. Company Details
Table 84. Pfizer Inc. Business Overview
Table 85. Pfizer Inc. Melanocortin Receptor 4 Product
Table 86. Pfizer Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021) & (US$ Million)
Table 87. Pfizer Inc. Recent Development
Table 88. Retrophin Inc. Company Details
Table 89. Retrophin Inc. Business Overview
Table 90. Retrophin Inc. Melanocortin Receptor 4 Product
Table 91. Retrophin Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021) & (US$ Million)
Table 92. Retrophin Inc. Recent Development
Table 93. Rhythm Pharmaceuticals, Inc. Company Details
Table 94. Rhythm Pharmaceuticals, Inc. Business Overview
Table 95. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Product
Table 96. Rhythm Pharmaceuticals, Inc. Revenue in Melanocortin Receptor 4 Business (2016-2021) & (US$ Million)
Table 97. Rhythm Pharmaceuticals, Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanocortin Receptor 4 Market Share by Type: 2020 VS 2027
Figure 2. Bremelanotide Features
Figure 3. Corticotropin Features
Figure 4. Cosyntropin Features
Figure 5. Others Features
Figure 6. Global Melanocortin Receptor 4 Market Share by Application: 2020 VS 2027
Figure 7. Metabolic Disorder Case Studies
Figure 8. Women's Health Case Studies
Figure 9. Genito Urinary System Case Studies
Figure 10. Infection Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Melanocortin Receptor 4 Report Years Considered
Figure 13. Global Melanocortin Receptor 4 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Melanocortin Receptor 4 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Melanocortin Receptor 4 Market Share by Regions: 2020 VS 2027
Figure 16. Global Melanocortin Receptor 4 Market Share by Regions (2022-2027)
Figure 17. Global Melanocortin Receptor 4 Market Share by Players in 2020
Figure 18. Global Top Melanocortin Receptor 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanocortin Receptor 4 as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Melanocortin Receptor 4 Revenue in 2020
Figure 20. Global Melanocortin Receptor 4 Revenue Market Share by Type (2016-2021)
Figure 21. Global Melanocortin Receptor 4 Revenue Market Share by Type (2022-2027)
Figure 22. North America Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Melanocortin Receptor 4 Market Share by Type (2016-2027)
Figure 24. North America Melanocortin Receptor 4 Market Share by Application (2016-2027)
Figure 25. North America Melanocortin Receptor 4 Market Share by Country (2016-2027)
Figure 26. United States Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Melanocortin Receptor 4 Market Share by Type (2016-2027)
Figure 30. Europe Melanocortin Receptor 4 Market Share by Application (2016-2027)
Figure 31. Europe Melanocortin Receptor 4 Market Share by Country (2016-2027)
Figure 32. Germany Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Melanocortin Receptor 4 Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Melanocortin Receptor 4 Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Melanocortin Receptor 4 Market Share by Region (2016-2027)
Figure 42. China Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Melanocortin Receptor 4 Market Share by Type (2016-2027)
Figure 50. Latin America Melanocortin Receptor 4 Market Share by Application (2016-2027)
Figure 51. Latin America Melanocortin Receptor 4 Market Share by Country (2016-2027)
Figure 52. Mexico Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Melanocortin Receptor 4 Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Melanocortin Receptor 4 Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Melanocortin Receptor 4 Market Share by Country (2016-2027)
Figure 58. Turkey Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Melanocortin Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AstraZeneca Plc Revenue Growth Rate in Melanocortin Receptor 4 Business (2016-2021)
Figure 62. Mallinckrodt Plc Revenue Growth Rate in Melanocortin Receptor 4 Business (2016-2021)
Figure 63. Obexia AG Revenue Growth Rate in Melanocortin Receptor 4 Business (2016-2021)
Figure 64. Palatin Technologies, Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2016-2021)
Figure 65. Pfizer Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2016-2021)
Figure 66. Retrophin Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2016-2021)
Figure 67. Rhythm Pharmaceuticals, Inc. Revenue Growth Rate in Melanocortin Receptor 4 Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---